CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT)
Clinical trials for CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) explained in plain language.
Never miss a new study
Get alerted when new CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) trials appear
Sign up with your email to follow new studies for CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
ICU dialysis: which dose of blood thinner works best?
Disease control Recruiting nowThis study compares two starting doses (20 mg/h vs. 50 mg/h) of the blood thinner nafamostat in ICU patients receiving continuous kidney dialysis. The goal is to see which dose keeps the dialysis filter working longer without causing bleeding. About 92 adults with normal clotting…
Matched conditions: CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT)
Phase: PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
New dialysis recipe may cut electrolyte losses in ICU kidney patients
Disease control Recruiting nowThis study tests a modified dialysis method for ICU patients with acute kidney injury. The goal is to see if a special citrate-based protocol reduces the need for extra electrolytes like potassium and magnesium. About 43 adults will take part, and researchers will compare the new…
Matched conditions: CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT)
Phase: NA • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control
Last updated May 26, 2026 05:44 UTC
-
New dialysis fluid aims to prevent blood clots in kidney patients
Disease control Recruiting nowThis study tests the safety of a new solution called Prismocitrate 18 in 40 adults who need continuous kidney dialysis (CRRT) in the hospital, often due to acute kidney injury. The solution helps prevent blood clots in the dialysis machine and replaces some kidney functions. Rese…
Matched conditions: CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT)
Phase: PHASE3 • Sponsor: Vantive Health LLC • Aim: Disease control
Last updated May 26, 2026 04:37 UTC